WASHINGTON (MedPage Today) — It’s sometimes hard to get your feet tanned, but those who use a portable foot tanning device called the Tootsie Tanner risk overexposure to ultraviolet radiation, the FDA said in a prepared statement.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — Physicians must “embrace rather than resist change” under the new healthcare reform law, three administration officials wrote in an article published in the Aug. 24 issue of the Annals of Internal Medicine.
No Comments »
Filed under: General Health News
(MedPage Today) — Many patients who are on prescription drugs believe pharmaceutical companies have too much influence over their physicians’ prescribing practices, a new survey says.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — A federal judge ruled today that the Obama administration’s plan to provide federal funds for research using embryonic stem cells violated a federal law that bars the use of government money to destroy human embryos.
No Comments »
Filed under: General Health News
(MedPage Today) — Congress has joined the FDA and the CDC in taking a hard look at Iowa-based companies that sent eggs contaminated with Salmonella enteritidis to at least 17 states, sickening hundreds of people.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — It’s sometimes hard to get your feet tanned, but those who use a portable foot tanning device called the Tootsie Tanner risk overexposure to ultraviolet radiation, the FDA said in a prepared statement.
No Comments »
Filed under: Pharmacy News
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the first patient has been treated in its clinical trial of STA-9090 in combination with docetaxel for the treatment of advanced solid tumor malignancies.
No Comments »
Filed under: Pharmacy News
PROLOR Biotech, Inc., a company developing next generation biobetter therapeutic proteins, today announced that it has received regulatory clearance from the U.S. Food and Drug Administration (FDA) to conduct a Phase II clinical trial in the U.S. of its longer-acting version of human growth hormone, hGH-CTP.
No Comments »
Filed under: Pharmacy News
Pharmasset, Inc. announced today that dosing has begun in a Phase 2b study of PSI-7977, a nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 200mg QD and 400mg QD in combination with pegylated interferon alfa 2a and ribavirin, the current standard of care (SOC) in patients [...]
No Comments »
Filed under: Pharmacy News
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,759,304, entitled “Targeting Complement Factor H For Treatment of Diseases”, covering the composition of matter for its lead product candidate, TT30, a novel [...]
No Comments »
Filed under: Pharmacy News
